IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 83 filers reported holding IGM BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $45,827 | -53.2% | 4,965 | -30.3% | 0.00% | – |
| Q1 2023 | $97,870 | +8.0% | 7,123 | +33.7% | 0.00% | – |
| Q4 2022 | $90,629 | -59.2% | 5,328 | -45.4% | 0.00% | – |
| Q3 2022 | $222,000 | +107.5% | 9,762 | +64.8% | 0.00% | – |
| Q2 2022 | $107,000 | -15.7% | 5,922 | +24.9% | 0.00% | – |
| Q1 2022 | $127,000 | -17.5% | 4,742 | -9.3% | 0.00% | – |
| Q4 2021 | $154,000 | -52.9% | 5,229 | +5.2% | 0.00% | – |
| Q3 2021 | $327,000 | -23.2% | 4,969 | -3.1% | 0.00% | – |
| Q2 2021 | $426,000 | +14.2% | 5,129 | +5.3% | 0.00% | – |
| Q1 2021 | $373,000 | -53.5% | 4,873 | -46.4% | 0.00% | – |
| Q4 2020 | $803,000 | +176.9% | 9,094 | +131.3% | 0.00% | – |
| Q3 2020 | $290,000 | -4.6% | 3,932 | -5.9% | 0.00% | – |
| Q2 2020 | $304,000 | +210.2% | 4,177 | +137.9% | 0.00% | – |
| Q1 2020 | $98,000 | +42.0% | 1,756 | -4.0% | 0.00% | – |
| Q4 2019 | $69,000 | – | 1,830 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
| Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
| Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
| Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
| Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
| Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
| Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
| Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
| Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
| Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |